These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Single-Cell Mass Cytometry of Acute Myeloid Leukemia and Leukemia Stem/Progenitor Cells. Zeng Z; Konopleva M; Andreeff M Methods Mol Biol; 2017; 1633():75-86. PubMed ID: 28735481 [TBL] [Abstract][Full Text] [Related]
6. Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones. de Boer B; Prick J; Pruis MG; Keane P; Imperato MR; Jaques J; Brouwers-Vos AZ; Hogeling SM; Woolthuis CM; Nijk MT; Diepstra A; Wandinger S; Versele M; Attar RM; Cockerill PN; Huls G; Vellenga E; Mulder AB; Bonifer C; Schuringa JJ Cancer Cell; 2018 Oct; 34(4):674-689.e8. PubMed ID: 30245083 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia. Cloos J; Harris JR; Janssen JJWM; Kelder A; Huang F; Sijm G; Vonk M; Snel AN; Scheick JR; Scholten WJ; Carbaat-Ham J; Veldhuizen D; Hanekamp D; Oussoren-Brockhoff YJM; Kaspers GJL; Schuurhuis GJ; Sasser AK; Ossenkoppele G J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553571 [TBL] [Abstract][Full Text] [Related]
8. High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML). Wang L; Gao L; Xu S; Gong S; Liu M; Qiu H; Xu X; Ni X; Chen L; Lu S; Chen J; Song X; Zhang W; Yang J; Hu X; Wang J Ann Hematol; 2014 Oct; 93(10):1685-94. PubMed ID: 24844781 [TBL] [Abstract][Full Text] [Related]
9. Clonal evolution of acute myeloid leukemia from diagnosis to relapse. Vosberg S; Greif PA Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278 [TBL] [Abstract][Full Text] [Related]
11. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia? Xu J; Jorgensen JL; Wang SA Clin Lab Med; 2017 Dec; 37(4):787-802. PubMed ID: 29128069 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation. Bastos-Oreiro M; Perez-Corral A; Martínez-Laperche C; Bento L; Pascual C; Kwon M; Balsalobre P; Muñoz C; Buces E; Serrano D; Gayoso J; Buño I; Anguita J; Diéz-Martín JL Eur J Haematol; 2014 Sep; 93(3):239-46. PubMed ID: 24702162 [TBL] [Abstract][Full Text] [Related]
13. Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting. Stevens BM; O'Brien C; Jordan CT; Jones CL STAR Protoc; 2021 Mar; 2(1):100248. PubMed ID: 33437968 [TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations. Deng DX; Zhu HH; Liu YR; Chang YJ; Ruan GR; Jia JS; Jiang H; Jiang Q; Zhao XS; Huang XJ Leuk Lymphoma; 2019 Sep; 60(9):2181-2189. PubMed ID: 30773106 [TBL] [Abstract][Full Text] [Related]
15. Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding. Maetzig T; Lieske A; Dörpmund N; Rothe M; Kleppa MJ; Dziadek V; Hassan JJ; Dahlke J; Borchert D; Schambach A Cells; 2022 Dec; 11(24):. PubMed ID: 36552809 [TBL] [Abstract][Full Text] [Related]
16. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings. Cui W; Zhang D; Cunningham MT; Tilzer L Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197 [TBL] [Abstract][Full Text] [Related]
17. Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry. Fuda F; Chen W Curr Hematol Malig Rep; 2018 Dec; 13(6):455-466. PubMed ID: 30446941 [TBL] [Abstract][Full Text] [Related]
18. Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression. Kim T; Yoshida K; Kim YK; Tyndel MS; Park HJ; Choi SH; Ahn JS; Jung SH; Yang DH; Lee JJ; Kim HJ; Kong G; Ogawa S; Zhang Z; Kim HJ; Kim DD Leukemia; 2016 Feb; 30(2):295-302. PubMed ID: 26424407 [TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Dominietto A Curr Opin Hematol; 2011 Nov; 18(6):381-7. PubMed ID: 21986564 [TBL] [Abstract][Full Text] [Related]
20. [Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis]. Kern W; Haferlach T Med Klin (Munich); 2005 Jan; 100(1):54-9. PubMed ID: 15654545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]